$373 Million is the total value of New Leaf Venture Partners, L.L.C.'s 21 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DCPH | DECIPHERA PHARMACEUTICALS INC | $92,548,000 | -2.8% | 4,104,140 | 0.0% | 24.81% | -5.0% | |
| PRNB | PRINCIPIA BIOPHARMA INC | $87,147,000 | -2.4% | 2,625,713 | 0.0% | 23.36% | -4.5% | |
| ARVN | ARVINAS INC | $50,204,000 | +49.0% | 2,283,048 | 0.0% | 13.46% | +45.7% | |
| HARP | HARPOON THERAPEUTICS INC | $37,978,000 | +37.3% | 2,921,405 | 0.0% | 10.18% | +34.3% | |
| STIM | NEURONETICS INC | $19,304,000 | -18.0% | 1,543,115 | 0.0% | 5.17% | -19.8% | |
| ALEC | ALECTOR INC | $14,968,000 | +1.5% | 787,769 | 0.0% | 4.01% | -0.7% | |
| APTX | APTINYX INC | $10,989,000 | -17.5% | 3,290,079 | 0.0% | 2.94% | -19.3% | |
| OBSV | OBSEVA SA | $10,185,000 | -11.6% | 900,501 | 0.0% | 2.73% | -13.5% | |
| ITRM | ITERUM THERAPEUTICS PLC | $10,019,000 | -13.2% | 1,456,303 | 0.0% | 2.68% | -15.1% | |
| CMRX | CHIMERIX INC | $5,832,000 | +105.7% | 1,350,000 | 0.0% | 1.56% | +101.2% | |
| ARAV | New | ARAVIVE INC | $5,824,000 | – | 970,659 | +100.0% | 1.56% | – |
| UMRX | UNUM THERAPEUTICS INC | $4,704,000 | -40.3% | 1,795,545 | 0.0% | 1.26% | -41.6% | |
| XFOR | New | X4 PHARMACEUTICALS INC | $4,275,000 | – | 285,000 | +100.0% | 1.15% | – |
| CRNX | CRINETICS PHARMACEUTICALS INC | $4,193,000 | +9.9% | 167,700 | 0.0% | 1.12% | +7.5% | |
| AVRO | AVROBIO INC | $3,505,000 | -26.3% | 215,550 | 0.0% | 0.94% | -27.9% | |
| CHMA | CHIASMA INC | $2,988,000 | +43.7% | 400,000 | 0.0% | 0.80% | +40.5% | |
| SRRA | SIERRA ONCOLOGY INC | $2,811,000 | -67.3% | 5,020,446 | 0.0% | 0.75% | -68.0% | |
| NERV | Buy | MINERVA NEUROSCIENCES INC | $2,531,000 | -23.9% | 449,500 | +6.2% | 0.68% | -25.7% |
| AFMD | AFFIMED N V | $2,103,000 | -31.7% | 732,774 | 0.0% | 0.56% | -33.1% | |
| PDSB | New | PDS BIOTECHNOLOGY CORP | $702,000 | – | 117,242 | +100.0% | 0.19% | – |
| AVEO | AVEO PHARMACEUTICALS INC | $271,000 | -17.9% | 402,118 | 0.0% | 0.07% | -18.9% | |
| Exit | PDS BIOTECHNOLOGY CORP | $0 | – | -117,242 | -100.0% | -0.24% | – | |
| VSAR | Exit | ARAVIVE INC | $0 | – | -970,659 | -100.0% | -1.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.